+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Microbiome Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • PDF Icon

    Report

  • 117 Pages
  • May 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5807552
Description Jump to:
Microbiome Therapeutics Market is expected to grow at 32% by 2031. Microbiome therapeutics market is an emerging market with abundant opportunities in today's world. During the forecast period market experts suggest that number of products currently involved in clinical trials proves the amount of research and development activities carried out across the world focusing on microbiome therapeutics. Considering the structure of the microbiome market the potential is quite large. The key factors assisting the growth of this market comprise rising geriatric population, increasing incidences of lifestyle diseases, increasing demand for treatments with high efficiency and low side effects. The major factors that are expected to restrain the growth of this market are lack of broad research to aid the market pull, low awareness among the population related to the efficient usage and effect of prebiotics and probiotics, and impending government regulations on probiotics and prebiotics. The segmentation of microbiome market comprises of type of drugs, diseases, and geography.

Market experts suggest that the microbial landscape of human body has attracted more than US$ 650 Mn since 2010. In recent years, probiotics, or beneficial gut bacteria therapy, have been popular. These products possess capacity of preventing number of diseases by restoring the human microbiome to its natural state. However, the overall microbiome therapeutics market is still in its infancy; hence, cannot be used as a replacement for medication or as a treatment for the eradication of the disease. Europe was observed as the leading regional market for microbiome therapeutics followed by North America. The key factors assisting the microbiome therapeutics market in Europe are due to high acceptance and rising awareness of probiotic and prebiotic products. Asia-Pacific was observed as the most potential region in terms of population and prevalence of disease throughout the forecast period.

Key Players Identified for Microbiome Therapeutics Market Include but are Not Limited to:

OpenBiome, Seres Therapeutics Inc., 4D Pharma plc., Locus Biosciences, Inc., Enterome SA, Finch Therapeutics Group, Inc., Intralytix, Inc., Microbiotica, Second Genome, Rebiotix Inc., Vedanta Bioscience, Inc. And Other Notable Players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Microbiome Therapeutics market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Microbiome Therapeutics market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

  • FMT
  • Microbiome Drugs

Application

  • C. difficile
  • Crohn's disease
  • Inflammatory Bowel Disease
  • Diabetes
  • Others

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Microbiome Therapeutics market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Microbiome Therapeutics market?
  • Which is the largest regional market for Microbiome Therapeutics market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Microbiome Therapeutics market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Microbiome Therapeutics market worldwide?

This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Microbiome Therapeutics Market
2.2. Global Microbiome Therapeutics Market, By Type, 2022 (US$ Million)
2.3. Global Microbiome Therapeutics Market, By Application, 2022 (US$ Million)
2.4. Global Microbiome Therapeutics Market, By Geography, 2022 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2022
3. Microbiome Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Microbiome Therapeutics Market Vendors
3.2. Strategies Adopted by Microbiome Therapeutics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Microbiome Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Microbiome Therapeutics Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. FMT
5.3.2. Microbiome Drugs
6. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. C. difficile
6.3.2. Crohn’s disease
6.3.3. Inflammatory Bowel Disease
6.3.4. Diabetes
6.3.5. Others
7. North America Microbiome Therapeutics Market, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
7.3. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
7.4.Microbiome Therapeutics Market: By Region, 2021-2031, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
7.4.1.1.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
7.4.1.2.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
7.4.1.3.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
8. UK and European Union Microbiome Therapeutics Market, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
8.3. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
8.4.Microbiome Therapeutics Market: By Region, 2021-2031, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
8.4.1.1.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
8.4.1.2.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
8.4.1.3.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
8.4.1.4.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
8.4.1.5. France
8.4.1.5.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
8.4.1.5.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
8.4.1.6.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
9. Asia Pacific Microbiome Therapeutics Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
9.3. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
9.4.Microbiome Therapeutics Market: By Region, 2021-2031, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
9.4.1.1.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
9.4.1.2.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
9.4.1.3. India
9.4.1.3.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
9.4.1.3.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
9.4.1.4.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
9.4.1.5.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
9.4.1.6.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
10. Latin America Microbiome Therapeutics Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
10.3. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
10.4.Microbiome Therapeutics Market: By Region, 2021-2031, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
10.4.1.1.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
10.4.1.2.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
10.4.1.3.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
11. Middle East and Africa Microbiome Therapeutics Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
11.3. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
11.4.Microbiome Therapeutics Market: By Region, 2021-2031, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
11.4.1.1.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
11.4.1.2.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
11.4.1.3.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
12. Company Profile
12.1. OpenBiome
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Seres Therapeutics Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. 4D Pharma plc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Locus Biosciences, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Enterome SA
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Finch Therapeutics Group, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Intralytix, Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Microbiotica
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Second Genome
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Rebiotix Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Vedanta Bioscience, Inc.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Other Notable Players
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
List of Figures
Figure. 1 Global Microbiome Therapeutics Market: Market Coverage
Figure. 2 Research Methodology and Data Sources
Figure. 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure. 4 Global Microbiome Therapeutics Market: Quality Assurance
Figure. 5 Global Microbiome Therapeutics Market, By Type, 2022
Figure. 6 Global Microbiome Therapeutics Market, By Application, 2022
Figure. 7 Global Microbiome Therapeutics Market, By Geography, 2022
Figure. 8 Market Geographical Opportunity Matrix - Global Microbiome Therapeutics Market, 2022
Figure. 9 Market Positioning of Key Microbiome Therapeutics Market Players, 2022
Figure. 10 Global Microbiome Therapeutics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure. 11 Global Microbiome Therapeutics Market, By Type, 2022 Vs 2031, %
Figure. 12 Global Microbiome Therapeutics Market, By Application, 2022 Vs 2031, %
Figure. 13 U.S. Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 14 Canada Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 15 Rest of North America Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 16 UK Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 17 Germany Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 18 Spain Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 19 Italy Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 20 France Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 21 Rest of Europe Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 22 China Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 23 Japan Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 24 India Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 25 Australia Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 26 South Korea Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 27 Rest of Asia Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 28 Brazil Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 29 Mexico Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 30 Rest of Latin America Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 31 GCC Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 32 Africa Microbiome Therapeutics Market (US$ Million), 2021 - 2031
Figure. 33 Rest of Middle East and Africa Microbiome Therapeutics Market (US$ Million), 2021 - 2031
List of Tables
Table 1 Global Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 2 Global Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 3 North America Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 4 North America Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 5 U.S. Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 6 U.S. Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 7 Canada Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 8 Canada Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 9 Rest of North America Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 10 Rest of North America Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 11 UK and European Union Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 12 UK and European Union Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 13 UK Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 14 UK Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 15 Germany Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 16 Germany Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 17 Spain Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 18 Spain Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 19 Italy Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 20 Italy Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 21 France Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 22 France Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 23 Rest of Europe Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 24 Rest of Europe Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 25 Asia Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 26 Asia Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 27 China Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 28 China Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 29 Japan Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 30 Japan Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 31 India Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 32 India Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 33 Australia Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 34 Australia Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 35 South Korea Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 36 South Korea Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 37 Latin America Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 38 Latin America Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 39 Brazil Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 40 Brazil Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 41 Mexico Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 42 Mexico Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 43 Rest of Latin America Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 44 Rest of Latin America Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 45 Middle East and Africa Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 46 Middle East and Africa Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 47 GCC Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 48 GCC Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 49 Africa Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 50 Africa Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
Table 51 Rest of Middle East and Africa Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
Table 52 Rest of Middle East and Africa Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)

Companies Mentioned

  • OpenBiome
  • Seres Therapeutics Inc.
  • 4D Pharma plc.
  • Locus Biosciences Inc.
  • Enterome SA
  • Finch Therapeutics Group Inc.
  • Intralytix Inc.
  • Microbiotica
  • Second Genome
  • Rebiotix Inc.
  • Vedanta Bioscience Inc

Related Topics

Related Reports

Human Microbiome Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Disease Type, and Geography - Product Image

Human Microbiome Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Disease Type, and Geography

  • Report
  • 174 Pages
  • Global
From
Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral, Rectal), CDMO (Formulation, Strain Engineering), Type (BCT/FMT, Live Bacteria) - Global Forecast to 2031 - Product Image

Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral, Rectal), CDMO (Formulation, Strain Engineering), Type (BCT/FMT, Live Bacteria) - Global Forecast to 2031

  • Report
  • 371 Pages
  • Global
From
Microbiome Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Microbiome Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Human Microbiome Market Size, Share, Trends and Forecast by Product, Application, Disease Type, and Region, 2025-2033 - Product Image

Human Microbiome Market Size, Share, Trends and Forecast by Product, Application, Disease Type, and Region, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Microbiome Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Microbiome Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.